Correlation Between Johnson Johnson and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Bristol Myers Squibb, you can compare the effects of market volatilities on Johnson Johnson and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Bristol Myers.

Diversification Opportunities for Johnson Johnson and Bristol Myers

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Johnson and Bristol is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Bristol Myers go up and down completely randomly.

Pair Corralation between Johnson Johnson and Bristol Myers

Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Bristol Myers. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 4.33 times less risky than Bristol Myers. The stock trades about -0.01 of its potential returns per unit of risk. The Bristol Myers Squibb is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  117,221  in Bristol Myers Squibb on August 23, 2024 and sell it today you would lose (16,666) from holding Bristol Myers Squibb or give up 14.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy43.75%
ValuesDaily Returns

Johnson Johnson  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.
Bristol Myers Squibb 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.

Johnson Johnson and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Bristol Myers

The main advantage of trading using opposite Johnson Johnson and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Johnson Johnson and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data